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ABSTRACT 
 
In the 200,000 years that humans have existed in our current homo sapien sapien form, 
we built our civilizations based in part on our desire to understand the world around us. 
The difficult part about this is the fact that our world has grown so vast and so quickly 
(think Moore’s Law, the observation that the speed and capability of computers is 
projected to double each year with an increasing number of transistors that can fit into a 
microchip), especially within the past century, that many people have been left behind 
due to their capability to understand. This gap in understanding is extremely problematic 
when it comes to issues of importance, such as politics and business. For example, a 
significant portion of the population does not understand the electoral college and its role 
in ensuring that the few do not decide for the many in our Presidential elections. On a 
more personal note, healthcare is unnecessarily complex, from advancements in 
treatment, the structure of insurance, how care itself is delivered, and how “health” is 
perceived. While one guide cannot cover all of the intricacies of the medical field, this 
thesis discusses a complex disease that affects millions of patients and their families each 
year. Cancer biology, treatment, and research will be explained using science, history, 
and mathematics in layman’s terms.  
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INTRODUCTION 
Of the prevalent yet misunderstood human afflictions, cancer is perhaps the most 
prevalent and most misunderstood of them all. Basic cancer rates are relatively 
straightforward to quantize. In a 2015 study, the Centers for Disease Control and 
Prevention (the CDC) determined that cancer is the second leading cause of death in the 
United States, surpassed only by heart disease [1]. In total, one in four deaths in the 
United States is due to cancer. 
         Cancer rates (from the same 2015 study), both by new cases reported and by 
death, were determined per 100,000 people for each state. The national average for 
diagnosis was 438 and 159 for death. The State of Maine was one of four states that 
exceeded both of those averages with a new case rate of 468 (ranked 11th of 50 states) 
and a death rate of 177.5 (ranked 13th). There are many factors that may contribute to 
these sobering statistics, including the State’s aging population, rural landscape (which 
makes access to adequate medical care difficult for some), sedentary lifestyle, low 
screening rates, the prevalence of granite, the poor air quality from Maine being “the 
tailpipe of the nation,” and the state’s poverty rate [2,3].  
Risk factors such as these are apparent in all walks of life. Seemingly perfectly 
healthy people will be struck down by a disease that can manifest itself due to genetics, 
age, lifestyle, and even the environment. Ordinary people are often unprepared for the 
world of sickness, treatment, and remission. The average cancer patient may feel as 
though they have no power over this disease or their body. Everyone deserves to know 
exactly how their body works, how it might be malfunctioning, and what the possible 
treatment options are because individuals should have autonomous control over their 
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body, which is the only possession that truly belongs to them. Individuals always have 
choices as to how they interact with their disease, and this can be the difference between 
a successful or an unsuccessful treatment regime. Knowledge can empower these 
individuals to advocate for themselves and make more effective decisions. Lack of 
understanding is dangerous because it can (and has) led to people giving the power to 
make important decisions to others, who may or may not have their best interests in 
mind.  
At age nine, I watched an uncle and an aunt battle cancer unsuccessfully. Another 
uncle became sick a few years later and did not seek treatment. I had a basic 
understanding, from a very young age, about cancer and cancer treatment. My aunt 
explained to me why a stem cell transplant was necessary to treat her multiple myeloma 
and why she could not buy bread from the supermarket bakery in a way that made it seem 
like she had everything figured out. Whether or not understanding her treatment actually 
helped her, my aunt’s understanding most certainly helped my family cope when we 
realized that she was not going to get better. At age nine, I was not asking my aunt if 
being educated about her disease and treatment helped her to fight or at least cope. 
However, my personal understanding of the mechanisms behind the echocardiogram tests 
that followed reparative surgery for my heart murmur greatly helped my preteen self 
during check-ups.  
My relatives were generally educated about their disease, however many others 
are not. A 2008 study using data from the National Cancer Institute (the United States’ 
federal government leading agency for cancer research) found that when surveyed, less 
than half (44.9%) of Americans had ever searched for cancer information. Additionally, 
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and according to the same source, “Many [people] reported negative experiences, 
including the search process requiring a lot of effort (47.7%), expressing frustration 
(41.3%), and concerns about the quality of the information found (57.7%) [4].” 
It may seem like the greatest injustice to be thrust, generally weaponless, into the 
fight against cancer as a cancer patient, but this thesis is an attempt to arm the average 
person in this complex fight. Having a greater understanding of these things (medicine, 
business, law, technology) that make our existence complex offers improvement in the 
quality of life. Truly living requires more than simply going through the motions. Being 
better educated allows people to experience their own lives. In medicine, instead of 
experiencing cancer a vast unknown that requires professional interference and 
incomprehensible medicine, a person can approach it as a disease to be healed.  
A person should know what the difference is between a healthy cell and a cancer 
cell, understand the nature of cancer, know the risk factors, the treatment methods, and all 
of the ways in which cancer statistics, from research spending to screening statistics, can 
be extremely misleading. Knowledge is a powerful tool. It can change everything from 
your mindset to the type of treatment you receive to the outcome of your diagnosis. This 
thesis is one snapshot of the science, history, and mathematics of cancer for the everyday 
person.  
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PART I: THE CELLS THAT WORK TOO WELL 
According to the American Cancer Society, a nationwide voluntary health organization 
established in 1913, a person has a one in three chance of developing cancer as of 2019 
[5]. The vast majority of people will know someone, or many someones, who have been 
afflicted with cancer. In a group of three people, that someone who develops cancer may 
very well be you. While cancer is relatively common, knowledge about it is not. Cancer 
is an umbrella term that encompasses over a hundred distinct diseases, and that can be 
overwhelming. Cancer is a disease that is commonly feared because it is not understood 
due to that complexity. Despite (or perhaps due to) the justifiable fear, the statistic that 
one third of the world’s population has the chance of developing cancer shows just how 
imperative it is that everyone understand this disease because it does not discriminate. 
The very first step in this understanding is knowing how the most basic unit of life, the 
cell, functions when it is healthy and when it becomes cancerous.   
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CHAPTER I 
THE STUDY OF HEALTH 
         Modern medicine, and especially the medicine that characterizes Western 
civilizations such as the United States, can be classified as curative. This means that our 
current practices concerning our health are focused more on treating the disease, not the 
cause. We have a terrible habit of going through life without considering the 
consequences of science and taking for granted that everything works out as it is 
supposed to. The only time that we take a moment to reflect on how the world works is 
when curiosity peaks our interest, and that most often happens when we observe that it 
stops working as we expect it to. 
 To understand cancer, we must first have a grasp on science, and more 
specifically, on biology and how our bodies work when they are healthy. After all, cancer 
is a disease of the cell. Biology, the most tangible natural science, is often classified as 
the study of life [6]. Biology becomes its own discipline in science on the cellular level, 
because despite its leaning heavily on physics and chemistry to explain its phenomena, it 
is the cell that is the building block for all living things. 
Humans, and other complex animals, are composed of trillions of cells. Our cells 
are extremely varied in both shape and function, which is evident in the of study anatomy 
and physiology. Cells range from gigantic and branching (neurons) to simple water-filled 
sacs (red blood cells), and absolutely everything in between. Our cells are the basis for 
understanding how we function and included in that is the pathway to linking cancer as a 
disease to humans. Cellular biology is a vast and fascinating field. Studying the most 
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fundamental unit of what makes us living beings is extremely significant in 
understanding what we are and how we function [7]. Cells are more than a cycle of 
reproducing and dying, they are key to our living. 
For complex living things, cells compose tissues. Tissues, sometimes many 
different types of tissues, compose organs. Within our bodies many organs compose 
organ systems that allow us to operate the way that we do. Organs systems (nervous, 
cardiac, skeletal, pulmonary) come together to compose organisms such as ourselves. It is 
this hierarchy that allows a disease of the cells to become fatal to the entire organism. 
On the other end of the spectrum, cells are small units of life capable of a life 
cycle or growing, reproducing, and dying that is not overtly different from organisms 
such as ourselves. They have organelles not unlike our organs that perform specialized 
functions within the cell. Those organelles are composed of macromolecules which are 
formed from different elements which are collections of atoms, which make up all of 
matter, at their base.  
When considering cancer, the most important organelle in the cell is the nucleus, 
which is the main brain behind cell function. The nucleus is the overall control center of 
the cell, capable of sending directions for the cell to grow, divide, or die. In human cells, 
the nucleus is a membrane bound organelle that contains the genetic material of the cell, 
deoxyribonucleic acid (DNA), in multiple, linear molecules that are coiled into structures 
called chromosomes.  
DNA contains instructions necessary for the development, survival, and 
reproduction of an organism. These functions are transcribed into messages via 
ribonucleic acid (RNA) and then those messages are translated to produce proteins, 
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which are complex molecules that enable the physical work in our bodies. Each DNA 
sequence that becomes the instructions a function (sometimes these are proteins) is called 
a gene. Genes are only about one percent of the DNA sequence, or genome. The rest of 
the sequence is responsible for regulating the production of proteins as the cell requires.  
Normal, healthy cells will grow and divide as the body needs them to, and they do 
this in a process called the cell cycle. The cell cycle is the process by which a cell makes 
a copy of its DNA and then divides into two daughter cells. An important trait of the 
healthy cell is that it only functions while it is able to do its preprogrammed job. When 
cells get damaged or simply grow old, they die in a process called apoptosis 
(programmed cell death), which allows new cells to take their place.  
Understanding the cell cycle is key to understanding how cancer develops and 
how it can be treated. Many cancer-fighting medicines work by interfering with the cell 
cycle. To start, there are four stages of the cell cycle: G1, G2, M, and S. The “G” in G1 
and G2 stand for “gaps,” and during these stages, which occur in between the M and the 
S phases, nothing appears to be happening in the nucleus of the cell although the cell 
itself is very active and preparing to grow and divide. “S” stands for synthesis, which is 
the point in the cell cycle where DNA is replicated, and “M” stands for mitosis, which is 
the actual cell division. The two stages that are especially important in the conversation 
about cancer are synthesis and mitosis.  
DNA replication, or synthesis of the cell cycle, is the process by which each 
chromosome in the cell is copied. This requires a large number of enzymes, which are 
protein molecules that aid in biochemical reactions, such as those required to copy DNA. 
In DNA replication, each double-stranded DNA is unwound and the separate sides are 
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used as a template for a complementary strand. The end result is two identical copies of 
the genetic material.  
Mitosis is the phase of the cell cycle where a single cell divides into two daughter 
cells with identical genetic content of the parent cell. Cancer cells, however, do not 
always have the same genetic content as their parent cell. Mitosis occurs in four steps: 
prophase, metaphase, anaphase, and telophase. In prophase, the nuclear envelope that 
isolates the nucleus of the cell dissolves, chromosomes condense, and spindle fibers 
(protein fibers that provide structure for the dividing cell to move cell components and 
form the two new cells) form. In metaphase, the replicated chromosomes line up in the 
middle of the cell in preparation for division. Anaphase is where the chromosomes 
become elongated and form distinct poles, and during telophase, two nuclear envelopes 
form and new cell membranes are formed to create two cells.  
The time in which a cell is between cell divisions, and the phase that cells are in 
most of the time, is called interphase, where the cell is simply performing its function in 
the body. All of the above describes the normal, healthy cell. Cancer disrupts the 
normalcy and causes cells to grow out of control. The next chapter will describe how the 
cancerous cell develops and is different from the healthy cell. In context, cancer generally 
develops from mistakes in synthesis, and cancer treatment typically targets cells during 
mitosis.  
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CHAPTER II 
THE SUPERPOWERED CELLS 
         Cancer is the name of not one, but many different diseases of the cell. In general it 
describes the phenomena of uncontrolled cell growth, where some cells, instead of 
following the orderly process of the cell cycle, begin to divide without stopping and 
spread to surrounding tissues.  
 Despite cancer’s ability to manifest itself in over one hundred different diseases, 
all of them stem from one root cause: changes to the way that our cells grow and divide 
that result from changes to the genes that control the ways in which our cells function. In 
sum, cancer is a genetic disease.  As discussed previously, genes are specific sequences 
of DNA that code for a function. Genetic changes can be inherited from our parents or 
they appear during our lifetimes from errors that occur during cell division or from DNA 
damage caused by certain environmental factors. Errors during cell division are actually 
quite common, however there are many enzymes within the cell that work to fix these 
mistakes. The environmental factors that cause DNA damage are relatively well known, 
and include the smoke from cigarettes and excess exposure to UV radiation from the sun.  
 Any change in the DNA sequence of a cell is called a mutation. A mutation does 
not necessarily lead to cancer or a serious disease, some can actually be beneficial (e.g., 
virus immunity) or have no effect (e.g., result in different eye colors).  The gene changes 
that cause cancer are specific mutations that might increase the production of a protein 
that causes cells to grow or they might produce a misshapen protein that does not 
function normally, which would be especially detrimental if that protein’s function is to 
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repair cell damage. Cells with these genetic mutations have a tendency to develop 
additional mutations in other genes, and these compounded mutations can cause cells to 
become cancerous, where they grow without stopping and spread throughout the body.  
The cells in our bodies are meant to grow and divide to help us grow and function 
normally. However, cancer causes our cells to grow and divide to a greater extent than 
our bodies need, and in a sense, they are working too well [8]. The main consequence of 
cancerous cells is that they do not function as they are supposed to and they have the 
capability to crowd out normal cells and interrupt the function that they are meant to 
perform [9]. Take, for example, leukemia, which is cancer of the bone marrow where 
blood cells are formed. Blood cells, and in particular red blood cells, are responsible for 
transporting oxygen and nutrients to tissues all over the body and carbon dioxide and 
waste materials away from these tissues. Leukemia causes a build up of abnormal white 
blood cells, which normally help to fight infections, in the blood and bone marrow and 
effectively crowd out red blood cells so it is much harder for the body to deliver oxygen 
to its tissues, control bleeding, and fight infections.  
Any organ in the body is capable of developing cancer. This is because every 
organ is made up of tissues which are made up of cells, and each and every cell has DNA 
that codes for genes that have the capacity to undergo changes. There are many different 
kinds of cancer because the human body requires many different kinds of cells that 
perform the complex functions to keep us alive. Because our cells are so different, 
cancers of different types of cells are evidently different. Some types of cancer, such as 
melanoma, skin cancer, are very common and have entire populations of people that are 
more susceptible. Other cancers are rare, such as thyroid cancer, where less than two in 
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10,000 people are diagnosed each year. Some cancers spread quickly (lung cancer), and 
others take decades to develop, (non-Hodgkin’s lymphoma). Some, such as breast cancer, 
often result in tumors, or masses of cell growth (though a tumor is not always cancerous, 
some are benign), and others will not, as with blood cancer. Cancer is often named after 
the organ in which it originates, however there are many cancers subtypes that are 
distinguishable from which cells are affected or by the rate at which the cancer may 
spread. This explains the four common types of leukemia.  
Cancer varies by type as to its mortality rate. Some cancers are detected too late 
for any kind of effective treatment. This is often the case with pancreatic cancer, which is 
typically diagnosed as Stage IV cancer. A common trait of cancer is its tendency to 
spread to surrounding tissues, and this is termed metastasis. Metastasis occurs through the 
circulatory system or the lymphatic system and form metastatic tumors. The amount that 
the cancer has spread often corresponds to the seriousness of the disease. Prognosis is 
often measured in stages, numbered I through IV [10]. Stage I breast cancer means that 
the cancer is evident but still contained to its area of origin. Stage IV breast cancer means 
that cancer has spread to other parts of the body and successful treatment is more 
difficult. Other cancers are more deadly due to the nature of the cancerous cells. 
Glioblastoma, a form of brain cancer, is notoriously difficult to treat because its normal 
cells are star-shaped and develop tentacles when they become cancerous. These tumors 
are very difficult to remove via surgery and advance rapidly because they can control 
surrounding blood vessels that feed cancerous cells. 
In sum, cancer is a very complex disease. How it develops and the multitude of 
different disease types is a direct result of our complex cellular biology. These variations 
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also result in many different treatment procedures and risk factors, which will be 
discussed next. 
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PART II: AN UNNATURAL HISTORY & THE “RACE” TO CURE 
As long as cancer has been distinguishable from other diseases, people have been looking 
for cures [11]. Cancer research has been divided into two distinct branches: (i) a race to 
find a way to cure the typical cancer patient and, (ii) work to understand how cancer 
develops in the first place. Notable progress on the former started in the 1940s with Dr. 
Sidney Farber (after whom the Dana-Farber Cancer Institute was named) and his work to 
combat pediatric acute lymphoblastic leukemia [8,12]. This disease is a very rare form of 
blood cancer, and he turned to “antifolates,” which are synthetic chemicals that inhibit 
DNA replication. These efforts earned him the title of the father of modern 
“chemotherapy.” Almost fifty years before Dr. Farber started his first trials at Boston 
Children’s Hospital, Dr. William Halstead was performing radical surgery in an attempt 
to cure breast cancer and Dr. Emil Herman Grubbe was using radiation as a means to 
shrink tumors [13,14]. Today, these three treatment methods (chemotherapy, surgery, and 
radiation) have become much more precise and effective through many years of trial and 
error. Additional studies of cancer have brought to light common risk factors and possible 
new treatment methods such as immunotherapy and the controversial CRISPR 
technology. Cancer has followed a unique path through history. Even before scientists 
fully understood DNA, they were using X-rays to damage it in an attempt to cure cancer. 
Unlike a normal progression of events, cancer started large, with tumors and explosions 
of white blood cells, and has become small, with the discovery of its root cause (DNA 
damage). Somewhere in the middle, scientists and medical professionals were able to 
determine the factors that cause cancer, and that all sums to an unusual series of events. 
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CHAPTER III 
TREATMENT 
Scientists and physicians have been developing treatments for cancer long before 
we understood how it arises from a genetic disease. There are many variations of cancer 
treatment because of the variety of the disease itself, but also because of the differences 
between patients. The three main types of cancer treatment that have dominated the field 
in the past century and are still used today are chemotherapy, surgery, and radiation. 
Medical advancements and increased knowledge on what causes cancer have resulted in 
even more treatment types, which will be discussed in the next two chapters.  
 The cancer treatment that has a great deal of visibility, especially in the treatment 
of metastatic cancer, started ironically, as a poison. Chemotherapy (chemo) is the use of 
any medicine or any drug to treat any disease. In general, chemotherapy is a type of 
cancer treatment where anticancer drugs can be administered orally, through pills, or 
intravenously. 
During World War I, chemical warfare was introduced as a formidable weapon. 
Mustard gas, one of many chemical agents used at the time, was found to be effective in 
ceasing cell division, and provided the potential for a means of suppressing the cell 
division of cancerous cells. Thankfully, World War II did not see further use of chemical 
warfare on the battlefield, but it did see a new approach to cancer therapy pioneered by 
Dr. Sidney Farber. His work to use antifolates (anti-folic acid) to treat acute 
lymphoblastic leukemia was the beginning of modern chemotherapy. In fact, a drug that 
Dr. Farber worked with in the 1940s, methotrexate, is still used today. 
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Chemotherapy generally describes the treatment process whereby a selected drug 
or drugs, the order of their use, their dosages, and chronology of their use depend on the 
cancer (type, stage) and the patient (age, health, medical history). The intended use of 
chemotherapy is also considered, since the chemotherapy may be used in an effort to 
cure, to control, or simply to lessen the symptoms of the cancer. 
Anti-cancer drugs themselves work to target different stages of the cell cycle, 
thereby hindering the formation of new cells. Some specific anticancer drugs include 
alkylating agents (cause damage to a cell’s DNA, hinder reproduction), antimetabolites 
(interfere with DNA growth), anti-tumor antibiotics (changes the DNA of cells to keep 
them from growing and multiplying), topoisomerase inhibitors (interfere with enzymes 
called topoisomerases which aid in the process of copying DNA), mitotic inhibitors (stop 
cells from dividing), and corticosteroids (used to prevent nausea, vomiting, and severe 
allergic reactions). 
As chemotherapy drugs cannot always tell the distinguish between healthy cells 
and cancer cells (which do have a tendency to grow more quickly than normal cells), 
chemotherapy often causes damage to both. Unintended damage to healthy cells can 
cause many different side effects. Perhaps the most well known side effect of 
chemotherapy is hair loss, however the cells of the mouth, digestive tract, and 
reproductive system are commonly damaged by chemotherapy. In some cases, the side 
effect is more cancer as the cells in bone marrow are also at risk for damage, which can 
lead to leukemia. 
Not everyone undergoing chemotherapy experiences side effects, and every 
experience is different. There is a delicate balance between the chemotherapy drugs being 
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powerful enough to treat cancer but not so powerful that they cause serious side effects. 
Combinations of different anticancer drugs are often used to make treatment as effective 
as possible. Today, ongoing clinical trials are constantly making efforts to develop new 
drugs or better treatment plans (varying doses, orders, etc). Treatment today is 
significantly more effective and causes fewer side effects than it was one or more decades 
ago. 
Chemotherapy, which began as a cure for blood cancer, is especially useful to 
treat cancer that has spread throughout the body. Other therapies (radiation, surgery) are 
used to treat localized cancer. 
Surgery as a means of cancer treatment existed long before chemotherapy. At 
first, it was used only as a means to treat cancer. The best example of this is the radical 
mastectomy, which was a common treatment for breast cancer in the early to mid 1900s. 
William Halstead published a paper in 1894 documenting fifty cases of surgical therapy 
for breast cancer at Johns Hopkins Hospital. This procedure prevailed for over seventy 
years, and prompted the removal of all breast tissue, the surrounding skin, axillary lymph 
nodes, and muscles of the chest wall, including the pectoralis major, rectus abdominis, 
serratus anterior, subscapularis, latissimus dorsi, and the teres major muscle. While 
Halstead achieved an unparalleled survival rate, the patients who endured a radical 
mastectomy suffered from increased mortality rates from large, post operation wounds. 
Quality of life for these patients was severely decreased. With a compromised lymphatic 
system, women suffered from lymphedema. Removing the chest muscles restricted arm 
movement and resulted in chronic pain in addition to the radical disfigurement. Later 
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studies would reveal that radical mastectomies did not improve the chances of patient 
survival if the cancer was in a later stage.  
Starting in the mid 1900s, cancer surgery has become much less invasive. Surgery 
is perhaps the most evolved form of cancer treatment and serves a significant percentage 
of cancer patients (especially breast cancer). In modern medicine, this method of cancer 
treatment is generally used to remove the physical manifestations of cancer, such as 
tumors. However, it is also used to prevent, diagnose, stage, and treat cancer. A physician 
can take a tissue sample of a lump or a growth and analyze it for cancerous cells (a 
biopsy). He or she can fully remove a growth or lump as a preventative measure or as 
treatment. Physicians can also use surgery to observe surrounding organs and lymph 
nodes to see if the cancer has spread, which is called staging. In some cases, surgery is 
only a means of relieving the symptoms of cancer if full removal is not possible or would 
damage other organs. Cancer surgery has also evolved to reduce risks associated with any 
surgery. New techniques including using lasers, cryogenics, electrical currents, 
radiofrequency, and other methods are meant to reduce the invasive nature and improve 
the effectiveness of surgery. 
Two years after Dr. Halstead presented the results of his radical mastectomy 
trials, German physics professor Wilhelm Conrad Röntgen presented on his discovery of 
X-rays. X-rays refer to a specific, high energy wavelength range of electromagnetic 
radiation. Even before understanding the physical properties of X-rays and their effects 
on human biology, new techniques involving X-rays were being developed for cancer 
treatment. First, what we know as radiation therapy, or radiotherapy, involved using X-
rays as a way to image and detect possible tumors. These techniques evolved to include 
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other types of radiation (gamma rays, electron beams, or protons) and to treat cancer with 
advances in radiation physics and computer technology. This type of treatment uses high-
energy waves projected onto cancer cells to make small breaks in the DNA within the 
cells. This effectively stops the cells from growing and dividing, and then the cells will 
die. Radiation can also affect nearby healthy cells, but most will recover and resume their 
original functions. 
         At the beginning of the twentieth century, breast cancer and skin cancer were 
treated using radiation. With the ability to create high energy X-rays to treat deeper 
cancers, radiation was discovered to have the capability to both treat and to cause cancer. 
In early trials, before there were systems to focus the radiation onto local tumors and 
before dosing was determined, the benefits from cancer treatment were not balanced by 
the side effects they caused. Even today, the most common side effects are fatigue and 
hair loss and skin changes in the specific targeted area of treatment.  
Radiation therapy as cancer treatment is very common. There are two main types 
of radiation therapy which are essentially external beam or internal. The type of treatment 
depends on your specific cancer, such as tumor location and other planned treatment. 
External beam radiotherapy is given by a specialized machine capable of aiming radiation 
to specific target areas such as your chest for lung cancer. Internal radiotherapy is where 
a source of radiation is put inside your body and this could be in liquid (systemic therapy) 
or solid (brachytherapy) form.   
Radiation is used to treat many different types of cancer, however the treatment 
itself is only effective for localized cancer. Radiation may be the only treatment that a 
patient needs, or it might be used with other treatments to improve the effectiveness of 
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those treatments. In some cases, radiotherapy is used for localized cancers where surgery 
is not possible, such as cancer of the eye. 
Developing effective cancer treatment has been a long road of trial and error. 
Even today, with treatments that surpass historical methods by lightyears, there is room 
to improve. 
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CHAPTER IV 
FUTURE PRACTICES 
         The current methods of cancer treatment encompass three broad yet distinct fields 
of study, which is a significant arena in which to explore cancer treatment. All three have 
been around for a century or more, at least in theory, and have developed from sometimes 
disastrous beginnings to be effective treatment methods. Another worthwhile note, and an 
observable fact in most of modern American medicine, is that all three of these 
treatments are known as “curative” medicine, in comparison to preventative medicine. 
         A common critique of curative medicine is that the treatment is for the symptom, 
which is significantly less effective than treating the cause. As cancer treatment has 
benefited from the vast amount of knowledge we have gained in the field of cellular 
biology, both treatments and studies into the causes of cancer are continually improving. 
This rather illogical progression, from cancer to the cell, which also resembles our trek 
through chemistry and physics, is nothing new in the process of human discovery. 
Preventative medicine, on the other hand, is rarely talked about because it is not 
economic. In the case of cancer, given what we know about genetic mutations, this is 
probably not in our near future because of the ethical concerns of gene editing. However, 
the technology exists that could make this a reality. Hopefully by the time this happens, 
we understand enough about ourselves to use it responsibly. There is a medical middle 
ground between preventative and curative medicine which encompasses early detection 
and early action. 
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         An up and coming cancer treatment is immunology, or the branch of biology 
concerned with the immune system, the organs, cells, and substances within the body that 
provide protection against infections and some diseases [15]. Any foreign substance, such 
as a germ, will be recognized by the immune system and “attacked.” The immune system 
falls short with cancer cells because these are not always different enough from healthy 
cells for the immune system to recognize them, or the response of the immune system is 
not strong enough to destroy the cancer cells. 
         Researchers have developed several ways to aid the immune system in 
recognizing and destroying cancer cells, including monoclonal antibodies (man-made 
immune system proteins) that can be designed to attack specific parts of a cancer cell, 
cancer vaccines which will start an immune response to certain diseases, or immune 
checkpoint inhibitors, which are a general aid to the immune system. A great advantage 
of immunology is its use of systems that are already within the body. 
         A possible future cancer treatment method may employ CRISPR (clustered 
regularly interspaced short palindromic repeats) technology, a family of DNA sequences 
found in organisms such as bacteria and archaea that can be reprogrammed to track down 
and edit genes in any organism [16]. As our genes are the code for everything that makes 
us who we are, this is an extremely powerful and dangerous tool. CRISPR is not 
currently being used for cancer treatment. Currently, it is being used in clinical trials to 
reduce genetic deafness in mice, but the potential, and the excitement, is already there 
and moving quickly. The human genome was successfully mapped only fifteen years ago 
and this is a large advancement. 
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These are the future of cancer treatment, the development of which has only been 
possible from past trial and error. 
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CHAPTER V 
RISK FACTORS 
         When Sidney Farber first started developing chemotherapy in 1947, the root cause 
of cancer was still unknown. Years of research revealed that genetic mutations that cause 
cancer cells to divide uncontrollably, and these genetic mutations can occur from 
inherited traits, carcinogens, age, and even lifestyle choices. The average person who has 
a chance to become a cancer patient (meaning everyone) can utilize the powerful tool of 
understanding risk factors to lower the odds of developing cancer.  
 Increasing awareness about the link between health and cancer risk is a critical 
step for everyone in understanding cancer. One of the best ways to prevent cancer before 
it has even started is to take care of your body with proper diet, exercise, and lifestyle [9].  
Some aspects of a healthy lifestyle reducing cancer risk are not widely known. 
Even smoking cigarettes (and other tobacco products), which has long been a known 
cause of lung cancer, was not properly advertised as such on cigarette packs until the 
1960s. Physicians and scientists have understood the link between smoking tobacco and 
cancer since the 1760s, however tobacco companies were not keen to add warning labels 
with the word “cancer” on them [8]. This is not the only example of industries putting 
profits before human health. Today, smoking is still the cause of 90% of lung cancer 
cases in men and 80% of lung cancer cases in women. Lung cancer is the second most 
common type of lung cancer (after skin cancer) and it is the deadliest of all cancers. 
Taking protective measures like quitting smoking, not smoking at all, and avoiding 
secondhand smoke will all drastically reduce lung cancer risk. Avoiding environmental 
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factors such as radiation exposure, knowing your family history for lung cancer, being 
vaccinated against HIV, and maintaining a healthy lifestyle will also lower your risk of 
lung cancer.  
Many common cancers have similar risk factors that can be easily reduced 
provided more awareness and understanding. Wearing sun protection and avoiding direct 
sunlight in the middle of the day is an effective way to lower your risk of many types of 
skin cancer. Staying active and eating a healthy diet has been linked to lowered risk of 
breast, colorectal, esophagus, kidney, and pancreas cancers. Additionally, a healthy 
lifestyle has other health benefits such as lowered risk of heart disease. Certain viruses, 
including HIV, have been linked to cancer. Vaccinations against the human 
papillomavirus (HPV) during childhood are expected to prevent 90% of six types of 
cancer that can result from infections due to the virus. However, not every type of cancer 
is preventable by simply exercising or eating vegetables. 
Some people are at an increased risk for cancer because of inherited genes. For 
these types of cancer, there are no precautionary methods you can really take besides 
knowing your family history and the signs and symptoms in order to be screened 
effectively. Breast cancer, pancreatic cancer, melanoma, and retinoblastoma fall under 
this category or at least have been known to arise from inherited genes (breast cancer risk 
can be lowered by maintaining a healthy lifestyle and melanoma risk can be lowered by 
avoiding UV radiation, see above). One last, inevitable cancer risk factor that follows the 
same vein as inherited genes is age. 
The more common types of cancer are often age-related. Various tests have been 
developed to screen for these types of cancer, which can detect cancer before a patient 
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has developed any symptoms (which is not always a good thing, as we shall see). The 
guidelines for undergoing these screenings reflect the impact that age has on cancer risk. 
After age 40, women should consider getting annual mammograms to screen for breast 
cancer, and all women should be aware of what their breasts normally look and feel like. 
At age 45, people of average risk for colorectal cancer should be regularly screened. 
Women who are 21 and older should have a Pap test regularly to test for cervical cancer. 
People who are at higher risk for lung cancer, those who are older than age 55 and have a 
significant smoking history, should get yearly screenings with a low-dose CT. Prostate 
cancer screening has pros and cons, which men need to be aware of starting at age 50 to 
decide whether or not to be tested. Women entering menopause should be told about the 
risks and symptoms of endometrial cancer. In total, over three-quarters of new cancer 
cases diagnosed are in people age 55 or older. 
Aside from risk, another important cancer factor to be familiar with are the 
symptoms of cancer. Some symptoms are prominent and warrant immediate attention, 
especially in the case of tumors, swollen lymph nodes, or unexplained, persistent weight 
loss or fatigue. However, as with the nature of cancer itself, risk and symptoms are highly 
varied due to the complexity of the disease. The important factor here is recognizing that 
staying healthy and aware of cancer risk does not have to be overly complicated. These 
two actions alone dramatically reduces the risk of many different kinds of cancer. We are 
only aware that we can reduce our cancer risk because cancer research has uncovered the 
mechanisms of cancer. This approach to a cure has come secondary to finding effective 
treatment, as discussed in the previous chapter, but more and more focus is going towards 
treating cancer itself, and not just its aftermath. 
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PART III: BY THE NUMBERS 
As with any science-based field, cancer involves mathematics and statistics. The turning 
point of Dr. Sidney Farber’s research was made possible because leukemia can be 
counted, or the amount of white blood cells in a sample can be quantized. However, 
where there are numbers, confusion often follows. In a 2017 study of high school 
students by the Thomas B. Fordham Institute, an overwhelming 34% of students cited 
math as their least favorite subject [17]. The runner up in this category was English 
language arts, however there is quite a difference when only 14% of students state that 
ELA as their least favorite. Mathematics, in spite of the difficulties, serves the important 
function of allowing us to see the big picture. Whether or not this is obvious, math is 
present in many of our daily interactions, from telling time to preparing food. So many 
life skills require a basic understanding of math and statistics. With cancer, numbers are 
equally as abundant. Everything from risk put into lifetime odds, money donated to a 
cancer research cause, and statistics that detail the effectiveness of screening and 
treatment can become complicated quickly because they are based on numbers.  
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CHAPTER VI  
RESEARCH SPENDING 
         Cancer research remains a budding field in its two pronged offense as described 
above. Improving current treatments, developing new methods, and gaining a better 
understanding of what causes cancer in the first place (and risk factors and methods to 
lower those risk factors) has taken a significant amount of time but also a significant 
amount of money. 
         Cancer research requires funding. Thankfully, human health is seen as an 
important investment to the federal government and cancer research has significant base 
ongoing funding. In 2019, $5.74 billion in cancer research was funded by the federal 
government through the National Cancer Institute (NCI), an affiliate of the National 
Institutes of Health (NIH) [18,19,20]. Researchers from universities and private research 
institutes, such as John Hopkins, St. Jude’s, Memorial Sloan Kettering Cancer Center, 
and others, compete for these research funds. Organizations like the American Cancer 
Society (ACS) and Susan G. Komen Foundation fundraise for research and those funds 
supplement grant money from the NCI, however non governmental funding is a drop in 
the bucket compared to the collective federal funds. This does not mean that privately 
funded institutions are not worth donating to, because both ACS and Susan G. Komen are 
more than just an intermediary for research. They both provide significant resources for 
those that need information or patients that require financial support. 
However, people should be fully informed about the non-profit organizations they 
chose to donate to [18]. Controversy in the early 2010s surrounding Susan G. Komen 
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began with their fundraising partnerships, CEO’s salary, and connections with companies 
that benefit from more breast cancer patients. Susan G. Komen, as of 2017, is reportedly 
donating about 40% of funds raised to cancer research, which is an improvement from 
only 21% in 2010, but still falls flat as an organization that has claimed to be “for the 
cure” [22]. In 1982, when Susan G. Komen was founded by Nancy Brinker, this 
organization was instrumental in spreading awareness of breast cancer, a disease 
previously viewed as too “taboo” for published newspapers [8]. It is up to an individual 
to decide if an organization’s mission and actions line up with their personal beliefs.  
Non-profit organizations do donate to research efforts, the amount, however, may 
come as a shock to some. Every company requires overhead. They need to keep their 
lights on and pay their employees. However, there is an amount that is reasonable, and an 
amount that might indicate your donation will be more effective elsewhere. While the 
NCI does provide lots of funding, money available for research grants is highly sought 
after and can be very restrictive. Perhaps a scientist working in a university lab has a 
creative idea on a new method of cancer treatment. They might benefit from discretionary 
funds, which can be delivered through the NCI or other charities, that would allow them 
to collect preliminary data and gain federal funding. 
As non-profit cancer organizations commonly subsist from public donations, 
those donors have a right to know where their funds are being channeled. If you do not 
agree with what annual reports are telling you, feel free to choose another organizations 
or cause. Something that few people think about when they donate to the cause is the fact 
that cancer research and drug development research in general is an extremely slow 
process. Years of clinical trials are required to put a new treatment on the market. If you 
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want to see your donation make an immediate effect, research probably is not a good 
choice. One of the best and overlooked ways that individuals can give to the cancer 
fighting effort is to contribute to charities that work to improve the quality of life for 
cancer patients.   
The fact that something as simple as donating money to help fight cancer can 
become so confusing so quickly, but understanding is very possible and very 
empowering. People just need to know what they should be looking at. 
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CHAPTER VII 
CANCER STATISTICS 
         If cancer funding turned out to be more complex than expected, cancer statistics 
are a completely different struggle. Perhaps the most difficult aspect of cancer research is 
the need to prove that work being done is effective. This sounds counterintuitive, but true 
because the nature of reported cancer statistics are more complex than numbers that can 
be easily reported. 
         For example, women have a one in nine chance of developing breast cancer 
during their lifetime, which is highest odds of any type of cancer. The fact that people 
generally fail to recognize this is the fact that cancer, along with being related to health 
and living environment, is also an age-related disease. At age 40, a woman’s odds of 
developing breast cancer are actually only one in 400. Risk grows exponentially with age, 
however general statistics do not reflect that. The odds of developing cancer, for both 
males and females, is one in three (cancer has decreased in males recently, the odds were 
previously one in two) and the odds of dying from cancer are one in five, but that is over 
an entire lifetime. 
         Of course, this is simply overall cancer risk. The complicated portion comes from 
measuring the effectiveness of cancer screening statistics as well as cancer treatment 
effectiveness. 
         To start, clinical trials have shown that routine screening for breast cancer, and 
other common cancer types such as cervical, colorectal, and lung cancer, does save lives. 
However, thanks to the evolving understanding of cancer screenings, recent trends have 
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shown that less screening is recommended. For breast cancer in women aged 50 to 59 in 
particular, 1,300 women need to be screened to save one life. There are even studies that 
show the excess screening can lead to false diagnosis and unnecessary anxiety. The 
confusion comes from the use of survival, the measurement of how long a person lives 
after diagnosis, to judge how effective cancer screening is at saving lives. 
         Survival is not an accurate measure of screening effectiveness due to two types of 
bias: lead-time and length [23]. Lead-time bias is when cancer screening finds the cancer 
earlier than the cancer symptoms would have revealed said cancer, but the earlier 
diagnosis does not change the course of the disease. This is best explained by the 
following example: “A man experiencing a persistent cough and weight loss is diagnosed 
with lung cancer at age 67, and he dies of his cancer at age 70. The five-year survival rate 
for this man, and others like him, is 0%. If this same man had been screened and his 
cancer detected earlier, perhaps at age 60, but he still dies at age 70, his life has not been 
extended, but the five-year survival rate is 100%.” This seemingly increased survival rate 
is inaccurate and completely misleading about the nature of cancer screenings. 
         Length bias, on the other hand, skews numbers and contributes to overdiagnosis. 
This is especially the case with slow-growing, less aggressive cancers, which will never 
cause harm or require treatment for the entirety of the patient’s lifetime. However, if 
screened, treatment will proceed and create another disproportionate five-year survival 
rate. The hypothetical example is that there are 1000 people with a form of progressive 
cancer. After five years, 400 are alive and 600 are dead. This means that the survival rate 
is 40%. When 2000 other patients are over diagnosed because their cancer is 
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nonprogressive, but the same 1000 people have a progressive cancer, the same number of 
people have died, but the survival rate appears to be 80%, an alarming discrepancy. 
 The odds of a person developing cancer, cancer screening, and treatment statistics 
can be misleading. Cancer is more than one mathematical expression that describes the 
risk for a person to develop any disease that was caused by uncontrolled cell growth at 
any time during their life. These numbers should be much more specific to age and 
cancer type, but one thing that is extremely effective is the fact that the advancements 
that brought this confusion also brought a greater understanding of the disease itself. The 
average person does not understand how cancer really and truly works, but, with a little 
help, they can. 
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CONCLUSION 
         Cancer, from its nature to its history to its numbers, is an undeniably complex 
disease. Despite the fact that this is a disease that has the capability to affect up to one 
third of the population, few understand how it works from start to finish. Even with the 
discussions started here, there is even more that contributes to the industry of cancer. This 
is merely one peak of the mountain of information a person must submit to fully 
understand medicine, but it is an excellent starting point. 
         The truth of cancer is darker than most people can imagine. This disease has 
inspired as massive, extremely lucrative industry that includes billion dollar non-profit 
organizations, companies that manufacture screening equipment, and the ever present 
“big pharma” still plugging away at that miracle drug that will save us all. When cancer 
patients are kept in the dark about the nature of their disease and their treatments, they are 
the ones that pay much more than money for a corporation’s greed. 
         Despite that, all hope is not lost. 
         The start is education. This does not have to be a formal education, but simply a 
call to be as educated as possible on the issues of importance. Our present world has the 
most extensive resource in finding information about anything anyone would ever want 
to know. This reaches much further than medicine, it is applicable to technology, 
business, politics, and sociology, to name a few. A person who wants to make a 
difference does not have to be an expert, they only have to be willing to learn and to 
teach those who are not educated. 
         Increased awareness will open up worlds of possibilities. Even coming to terms 
with the fact that cancer seems to be more prevalent today because medical advances 
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have kept people from dying in other situations is a beginning. The hospital delivery 
room and the influenza vaccine have saved countless lives during childbirth and flu 
season. It is also important to recognize that there are increased carcinogens in our 
environment and decreased health in developed countries that contribute to increasing 
cancer rates. 
         A large portion of the population will is asking for a cure for cancer, a magic 
bullet that will stop all suffering. This is not an easy subject, and this is not something 
that will exist in the same sense that allowed for the polio vaccine. We’ve gone through 
great lengths to oversimplify “a cure for cancer,” something that definitely should not be 
oversimplified. What would this even mean? Improving cancer treatment so that the 
survival rate is 100%? Developing a method of editing genes to avoid cancer altogether?  
Perhaps one improvement will involve humans becoming more accepting of our 
inevitable death, to remove this fear of the unknown and focus on what is truly important. 
         This disease is complex in everything but its root nature. It affects different 
organs, results in different symptoms, requires different treatment, and can be caused by 
different things. How cancer will manifest itself is different in each and every patient. 
Cancer is an undeniably complicated disease, but that should not prevent any person from 
being able to have a basic understanding. As with any subject, it can be broken down into 
its component parts and the understanding can be built from the ground up. This work is 
one version of an everyday guide to cancer. On another day we can create a layman’s 
guide to electronics? 
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